FDA Announces Draft Guidance for Sodium Reduction Efforts
The U.S. Food and Drug Administration (FDA) has issued draft guidance that would support reducing the average individual sodium intake by about 20% of consumer intake levels prior to 2021. In a news release, FDA said the voluntary sodium reduction targets would support reducing the average individual sodium intake to about 2,750 mg/day; prior to 2021, consumer intake averaged about 3,400 mg/day. “Reducing sodium in the food supply has the potential to be one of the most important public health initiatives in a generation,” FDA Deputy Commissioner for Human Foods Jim Jones said in a statement.
Read more stories in the Food and Beverage Litigation and Regulatory Update >>